Helmholtz Diabetes Center Institute of Diabetes Research

Pediatricians and computer scientists join forces at the Helmholtz Munich Institute for Diabetes Research to identify children with type 1 diabetes before they develop symptoms. With the help of advanced statistics and machine learning, the…

In a groundbreaking collaborative effort, academic researchers, industry leaders, and charities have joined forces to combat Type 1 Diabetes (T1D) with the support of a €22 million grant from the Innovative Health Initiative (IHI). EDENT1FI, which…

Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin. While the cause of the autoimmunity reaction is still unclear, viral infections in young children are proposed to be…

During the COVID-19 pandemic, an increase in the chronic autoimmune disease type 1 diabetes was observed in children, also in Germany. Researchers at Helmholtz Munich and TU Dresden, in cooperation with the Kassenärztliche Vereinigung Bayern (KVB),…

Most children displayed SARS-CoV2 immunity. In March 2023, SARS-CoV2 antibodies were present in 94% of the children, including infants.

With this new campaign, scientists want to raise awareness for early detection and prevention of type 1 diabetes in children.

In his testament, a deceased member of the Deutscher Diabetiker Bund (DDB) e. V. stated the will to support diabetes research with 200 000 Euro. The money was now donated to the Institute of Diabetes Research of Helmholtz Munich (IDF) led by…

Study provides novel insights on dynamics of blood sugar levels and autoimmunity in early childhood

When and why does type 1 diabetes manifest in children? For the first time, researchers conducted a long-term study on infants and young children…

Diabetes research: At this year's congress of the European Association for the Study of Diabetes (EASD), Helmholtz Munich scientists received several awards for pioneering ideas and ways to fight the disease.

Prof. Dr. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute of Diabetes Research (IDF) receives this year’s EASD–Novo Nordisk Foundation Diabetes Prize for Excellence. The prize is awarded to honor outstanding contributions to the…

It only takes a blood test to detect the autoimmune disease type 1 diabetes in children at an early stage and, thus, prevent severe metabolic derailments. Helmholtz Munich offers the world's largest population-based screening for type 1 diabetes in…

The 100th anniversary of the discovery of insulin is a milestone in diabetes research and insulin continues to be a lifesaver for many people. At the same time, the International Diabetes Federation predicts a rise in the number of diabetes cases to…

A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests. In addition, the researchers found that about…

Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘…

A new study lead by Helmholtz Zentrum München indicates a six-fold higher SARS-CoV-2 exposure rate among children in Bavaria, Germany, than reported cases. This highlights the value of population-based antibody screenings for pandemic monitoring. The…

Large-scale antibody testing against the new coronavirus SARS-CoV-2 could help to obtain reliable data on infection rates. Screening children for early stages of type 1 diabetes in Bavaria, "Fr1da-plus" will now integrate SARS-CoV-2 antibody testing…

Researchers at Helmholtz Munich employed the world's first early detection test for type 1 diabetes in a large-scale population study in Bavaria, Germany, and investigated its effects. For the first time, screening for islet autoantibodies makes it…

Starting November 10th, the Institute for Diabetes Research at Helmholtz Munich is carrying out a dialogue campaign titled “LASST UNS ÜBER 1 REDEN” to mark World Diabetes Day 2019 (14 November). The aim is to raise awareness of type 1 diabetes in the…

The Institute of Diabetes Research of the Helmholtz Munich has now registered 100,000 participants in the Bavarian study "Fr1da" on the early detection of type 1 diabetes. The study will be continued with an additional age group under the name…

It is a major milestone for one of Europe’s biggest health research cooperations: The international platform GPPAD (“The Global Platform for the Prevention of Autoimmune Diabetes”) has successfully screened 100,000 newborns across Europe for an…

This campaign will have impact in Germany: Since January 22, “Sche1sstyp” – a pun, literally “shit type”– has been emblazoned in large letters across 1500 posters in Munich, Berlin, Hanover and Dresden as well as on more than 560 info screens…

Children of mothers with type 1 diabetes are at significantly higher risk of being overweight and of exhibiting insulin resistance. This was published by scientists from Helmholtz Munich and the Technical University of Munich in the journal…

An international research group headed by scientists from Helmholtz Munich has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods. By analyzing up to 41 gene sites, it is…

Scientists at Helmholtz Munich have investigated methylation patterns of risk genes for type 1 diabetes. In the ‘Journal of Autoimmunity’ they report a strong methylation signal in the HLA region, which persists throughout life and leads to…